, especially in oncology, immunology and/or neuroscience. Have a familiarity of deal structuring in pharma/biotech, including the... and/or leading early stage or clinical-stage collaborations in pharma, biotech is required Track record of negotiating...
analysis of seed & biotech early-stage opportunities for Global deal as well as in-/out-licensing & M&A opportunities for Japan... deal Develop BD&L strategy for Bayer Japan in close collaboration with Head of Collaborate To Cure Japan Hub, Japan Pharma...
analysis of seed & biotech early-stage opportunities for Global deal as well as in-/out-licensing & M&A opportunities for Japan... deal Develop BD&L strategy for Bayer Japan in close collaboration with Head of Collaborate To Cure Japan Hub, Japan Pharma...
, Biology, Pharmaceutical Sciences or Life Science discipline. 5-10 years selling experience in pharma/biotech industry. Good...'s technologies portfolio. The role covers management of Cell & Gene Technologies customer portfolio in Japan, including pharma...
clients and cultivate existing relationships within the Japanese pharma and biotech sectors Drive Revenue Growth: Develop... to become the go-to partner for pharmaceutical and biotech companies. Are you keen to leverage your Healthcare network in Japan...
of Alexion Pharma GK (AP-J) as a whole, and carries it out in cooperation with MSL and the other Medical team (Medical... degree (M.D./Ph.D.) or equivalent scientific background and minimum of 4 years in the pharmaceutical or the biotech industry...
of strategic collaboration with all biotech and pharma customers. Small molecule and biological drug substance development... Executive -Japan Group / Division: Pharma Services Group (PSG) Position Location: Japan Location/Division Specific...
projects as well as within one or more of the following : Pharmaceutical, BioTech, Data Centre, Industrial, Logistics... and experience gained within a hi-tech environment such as industrial, manufacturing, pharma, logistics, offshore windfarms 応募...
Presenting a comprehensive recap of the week's highlights, spanning from top news to market performance, here's your market wrap for the week concluding on June 28, 2024. Continue Reading »
Indian stock market benchmarks—the Nifty 50 and the Sensex— ended the first half of the current calendar year with healthy gains, rising 10.5 per cent and 9.4 per cent, respectively. Continue Reading »
This initiative coincides with India’s inclusion in JPMorgan’s emerging market bond index on Friday. This inclusion is anticipated to attract an inflow of $20 billion to $25 billion over the next 10 months, as estimated by JPMorgan Continue Reading »
According to a report by Geojit, during the rally from 23,264 points to 24,041 points, the top five stocks are estimated to have contributed nearly 71% to the index's gains. In contrast, the bottom five stocks exerted a drag of approximately 27% on the index's performance during this period Continue Reading »
Nifty 50 index journey from 1,000 to 24,000 marked by rapid milestones and consistent growth, reaching 24,000 on June 27, 2024, with a remarkable 1,000-point rally in 0.8 months. Market cap increased by ₹12.2 lakh crore during this period, reflecting market dynamism and investor opportunities. Continue Reading »
Latest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your favourite companies. This blog keeps you informed on all things Dalal Street and global markets. Continue Reading »
With concerns of political and economic stability allayed, the upcoming Union budget and corporate earnings are expected to be the next big triggers for foreign investors in Indian equities Continue Reading »